Mm&m Partner Perspectives

No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers

Informações:

Sinopsis

Marc Iskowitz, MM&M's editor in chief, discusses a qualitative/quantitative approach to meeting orphan drug marketers' engagement challenge with Michael Carlin, vice president at TrialCard.